RA CAPITAL MANAGEMENT, L.P. Initiates New Position in Ascendis Pharma A/S (ASND)

RA CAPITAL MANAGEMENT, L.P., a registered investment adviser, initiated a new position in Ascendis Pharma A/S (NASDAQ:ASND) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.

The institutional investor purchased 10,281,496 shares of the Healthcare company, valued at approximately $2.2B as of the filing date.

Ascendis Pharma A/S's stock currently trades at $234.89 with a market capitalization of $12.7B.